Odyssey Therapeutics ODTX
NASDAQ ODTX
$19.36 +0.22 (+1.15%)
At close: Nov 16, 2026 · 4:00 PM EST

Odyssey Therapeutics (ODTX) Revenue (2023 - 2025)

Updated

Odyssey Therapeutics (ODTX) posted Revenue of $2.98 million for FY2025, down 33.5% from $4.47 million in FY2024.

Analysis

Odyssey Therapeutics (ODTX) Revenue (2023 - 2025) Analysis & Trends

  • Business Quant data shows ODTX's Revenue at $4.47 million in FY2024 (+331.2%) and $1.04 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 24.40 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 25.40 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 17.40 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 18.09 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 15.07 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 10.37 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 8.30 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 16.58 Bn
10 Odyssey Therapeutics 929.15 Mn -64.53 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 99,000.00
Jun 30, 2025 959,000.00
Mar 31, 2025 1.92 Mn
Dec 31, 2024 1.76 Mn
Dec 31, 2023 287,000.00
API Access

Odyssey Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=ODTX&period=max&api_key=YOUR_API_KEY